400 related articles for article (PubMed ID: 25277063)
21. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M
Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337
[TBL] [Abstract][Full Text] [Related]
22. Use of capillary blood to diagnose hereditary spherocytosis.
Crisp RL; Solari L; Gammella D; Schvartzman GA; Rapetti MC; Donato H
Pediatr Blood Cancer; 2012 Dec; 59(7):1299-301. PubMed ID: 22488885
[TBL] [Abstract][Full Text] [Related]
23. [Neonatal jaundice as a sign of Minkowski-Chauffard disease].
LELONG M; ALISON F; ALAGILLE D; DORMONT J
Rev Esp Pediatr; 1958; 14(81):313-37. PubMed ID: 13579547
[No Abstract] [Full Text] [Related]
24. Variations in both α-spectrin (SPTA1) and β-spectrin ( SPTB ) in a neonate with prolonged jaundice in a family where nine individuals had hereditary elliptocytosis.
Christensen RD; Nussenzveig RH; Reading NS; Agarwal AM; Prchal JT; Yaish HM
Neonatology; 2014; 105(1):1-4. PubMed ID: 24193021
[TBL] [Abstract][Full Text] [Related]
25. Identification of new mutations in patients with hereditary spherocytosis by next-generation sequencing.
Qin L; Nie Y; Zhang H; Chen L; Zhang D; Lin Y; Ru K
J Hum Genet; 2020 Apr; 65(4):427-434. PubMed ID: 31980736
[TBL] [Abstract][Full Text] [Related]
26. [Flow-assisted differential diagnosis of hemolytic anemia with spherocytosis: a case report].
Won DI
Korean J Lab Med; 2010 Aug; 30(4):339-44. PubMed ID: 20805704
[TBL] [Abstract][Full Text] [Related]
27. Update on the clinical spectrum and genetics of red blood cell membrane disorders.
Gallagher PG
Curr Hematol Rep; 2004 Mar; 3(2):85-91. PubMed ID: 14965483
[TBL] [Abstract][Full Text] [Related]
28. A prospective study to assess the predictive value for hereditary spherocytosis using five laboratory tests (cryohemolysis test, eosin-5'-maleimide flow cytometry, osmotic fragility test, autohemolysis test, and SDS-PAGE) on 50 hereditary spherocytosis families in Argentina.
Crisp RL; Solari L; Vota D; García E; Miguez G; Chamorro ME; Schvartzman GA; Alfonso G; Gammella D; Caldarola S; Riccheri C; Vittori D; Venegas B; Nesse A; Donato H
Ann Hematol; 2011 Jun; 90(6):625-34. PubMed ID: 21080168
[TBL] [Abstract][Full Text] [Related]
29. [Progress in research on red cell membrane disorders: from the genome to the postgenome era].
Yawata Y
Rinsho Ketsueki; 2001 May; 42(5):343-51. PubMed ID: 11452448
[No Abstract] [Full Text] [Related]
30. Different impacts of alleles alphaLEPRA and alphaLELY as assessed versus a novel, virtually null allele of the SPTA1 gene in trans.
Delaunay J; Nouyrigat V; Proust A; Schischmanoff PO; Cynober T; Yvart J; Gaillard C; Danos O; Tchernia G
Br J Haematol; 2004 Oct; 127(1):118-22. PubMed ID: 15384986
[TBL] [Abstract][Full Text] [Related]
31. [Flow cytometric test using eosin-5'-maleimide (EMA) labelling of red blood for diagnosis of hereditary spherocytosis].
Wang J; Zheng B; Zhao Y; Chen X; Liu Y; Bo L; Zheng Y; Zhang F; Ru K; Wang H
Zhonghua Xue Ye Xue Za Zhi; 2015 Jul; 36(7):598-601. PubMed ID: 26304086
[TBL] [Abstract][Full Text] [Related]
32. Clinical and molecular evaluation of non-dominant hereditary spherocytosis.
Miraglia del Giudice E; Nobili B; Francese M; D'Urso L; Iolascon A; Eber S; Perrotta S
Br J Haematol; 2001 Jan; 112(1):42-7. PubMed ID: 11167781
[TBL] [Abstract][Full Text] [Related]
33. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia.
King MJ; Behrens J; Rogers C; Flynn C; Greenwood D; Chambers K
Br J Haematol; 2000 Dec; 111(3):924-33. PubMed ID: 11122157
[TBL] [Abstract][Full Text] [Related]
34. Hematologically important mutations: spectrin and ankyrin variants in hereditary spherocytosis.
Gallagher PG; Forget BG
Blood Cells Mol Dis; 1998 Dec; 24(4):539-43. PubMed ID: 9887280
[No Abstract] [Full Text] [Related]
35. Clinico-hematological profile of hereditary spherocytosis: experience from a tertiary care center in North India.
Kar R; Rao S; Srinivas UM; Mishra P; Pati HP
Hematology; 2009 Jun; 14(3):164-7. PubMed ID: 19490762
[TBL] [Abstract][Full Text] [Related]
36. Hereditary spherocytosis diagnosed with the eosin-5'-maleimide binding test.
Watanabe T; Ono H; Tajima I; Ishigaki H; Hakamata A; Shirai M; Endoh A; Hongo T
Pediatr Int; 2014 Jun; 56(3):427-9. PubMed ID: 24894931
[TBL] [Abstract][Full Text] [Related]
37. A de novo ankyrin mutation (ANK1 Q109X) causing severe hereditary spherocytosis from preterm neonatal period.
Liu S; Jiang H; Huang LY; Li DZ
Ann Hematol; 2017 Jun; 96(6):1067-1068. PubMed ID: 28280995
[No Abstract] [Full Text] [Related]
38. Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
Kedar PS; Colah RB; Kulkarni S; Ghosh K; Mohanty D
Clin Lab Haematol; 2003 Dec; 25(6):373-6. PubMed ID: 14641141
[TBL] [Abstract][Full Text] [Related]
39. Advances in laboratory diagnosis of hereditary spherocytosis.
Farias MG
Clin Chem Lab Med; 2017 Jun; 55(7):944-948. PubMed ID: 27837594
[TBL] [Abstract][Full Text] [Related]
40. Beta-spectrinBari: a truncated beta-chain responsible for dominant hereditary spherocytosis.
Perrotta S; Della Ragione F; Rossi F; Avvisati RA; Di Pinto D; De Mieri G; Scianguetta S; Mancusi S; De Falco L; Marano V; Iolascon A
Haematologica; 2009 Dec; 94(12):1753-7. PubMed ID: 19608679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
